|
TOP2B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.752200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.104600E-01 |
| Normal-vs-Stage2 |
8.262800E-01 |
| Normal-vs-Stage3 |
5.092200E-01 |
| Normal-vs-Stage4 |
4.271000E-01 |
| Stage1-vs-Stage2 |
6.644400E-01 |
| Stage1-vs-Stage3 |
1.004020E-01 |
| Stage1-vs-Stage4 |
8.170400E-02 |
| Stage2-vs-Stage3 |
4.760600E-01 |
| Stage2-vs-Stage4 |
4.306200E-01 |
| Stage3-vs-Stage4 |
8.722600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.696800E-01 |
| Normal-vs-AfricanAmerican |
2.609000E-01 |
| Normal-vs-Asian |
3.948000E-01 |
| Caucasian-vs-AfricanAmerican |
3.510800E-01 |
| Caucasian-vs-Asian |
6.026600E-01 |
| AfricanAmerican-vs-Asian |
5.956600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.990800E-01 |
| Normal-vs-Female |
7.993200E-01 |
| Male-vs-Female |
5.911400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.467200E-01 |
| Normal-vs-Age(41-60Yrs) |
7.453600E-01 |
| Normal-vs-Age(61-80Yrs) |
3.227600E-01 |
| Normal-vs-Age(81-100Yrs) |
7.914800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.703400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.685600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.543400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.893570E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.764400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.299800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.608100E-02 |
| Classical-VS-Follicular |
6.30509999999251E-05 |
| Classical-VS-Other |
9.751800E-01 |
| Classical-VS-Normal |
6.898100E-02 |
| Tall-VS-Follicular |
4.816200E-01 |
| Tall-VS-Other |
3.219600E-01 |
| Tall-VS-Normal |
3.387800E-01 |
| Follicular-VS-Other |
2.562600E-01 |
| Follicular-VS-Normal |
6.241700E-02 |
| Other-VS-Normal |
6.758600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.043600E-01 |
| Normal-vs-N1 |
2.041000E-01 |
| N0-vs-N1 |
3.975800E-01 |
|
|
